Evidence map›Paper›PMID 40496271›Full record

ArticleJournal of immunology research2025

Roles of Mitochondrial Fusion and Division in Harmine Derivative H-2-168-Induced Neurotoxicity.

Yuehong Gong, Meichi Pan, Hang Ren, Dongling Peng, Meiling Zhao, Yicong Zhao, Chunlin Luo, Qin Ma, Hao Wen, Jianhua Wang

Abstract read
In one paragraph

Article in Journal of immunology research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yuehong GongDepartment of Pharmacognosy, Xinjiang Medical University, First Affiliated Hospital of Xinjiang Medical University, Urumqi 830011, Xinjiang, China.
Meichi PanDepartment of Pharmacognosy, School of Pharmacy, Xinjiang Medical University, Urumqi 830017, China.
Hang RenDepartment of Medicine, School of Pharmacy, Xinjiang Medical University, Urumqi 830017, China.
Dongling PengDepartment of Pharmacognosy, School of Pharmacy, Xinjiang Medical University, Urumqi 830017, China.
Meiling ZhaoDepartment of Pharmacognosy, School of Pharmacy, Xinjiang Medical University, Urumqi 830017, China.
Yicong ZhaoDepartment of Pharmacognosy, School of Pharmacy, Xinjiang Medical University, Urumqi 830017, China.
Chunlin LuoDepartment of Pharmacognosy, School of Pharmacy, Xinjiang Medical University, Urumqi 830017, China.
Qin MaResearch and Development Department, Xinjiang Huashidan Drug Research Co. Ltd., Urumqi 830011, China.
Hao WenState Key Laboratory of Pathogenesis, Prevention, and Treatment of High Incidence Diseases in Central Asia, Xinjiang Medical University, First Affiliated Hospital of Xinjiang Medical University, Urumqi 830011, Xinjiang, China.ORCID https://orcid.org/0000-0001-7144-220X
Jianhua WangDepartment of Pharmacognosy, Xinjiang Medical University, First Affiliated Hospital of Xinjiang Medical University, Urumqi 830011, Xinjiang, China.ORCID https://orcid.org/0000-0001-6090-1300

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

HarmineMitochondriaMitochondrial DynamicsNeuronsNeurotoxicity SyndromesAdenosine TriphosphateAnimalsApoptosisCell SurvivalDynaminsEnergy MetabolismGTP PhosphohydrolasesMembrane Potential, MitochondrialMitochondrial ProteinsPC12 CellsQuinazolinones3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinoneAdenosine TriphosphateDnm1l protein, ratDynaminsGTP PhosphohydrolasesHarmineMitochondrial ProteinsQuinazolinonesReactive Oxygen SpeciesDrp1H-2-168Mfn2mitochondrial fusion and divisionneurotoxicityPC12 cells

Identifiers

PMID40496271
PMCPMC12149512

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.